Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Spire

Showing results (191-200 of 335) with videos related to

Pageof 34
Sort By:
Drug and Alcohol Review|April 14, 2016
No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort)Fabienne Marcellin, Caroline Lions, Eric Rosenthal, et al.
BMJ Open|April 3, 2012
ANRS-COM'TEST: description of a community-based HIV testing intervention in non-medical settings for men who have sex with menKaren Champenois, Jean-Marie Le Gall, Cédric Jacquemin, et al.
Sexually Transmitted Infections|August 7, 2014
Comparison of risk factors in HIV-infected men who have sex with men, coinfected or not with hepatitis C virus (ANRS VESPA2 French cross-sectional national survey)Fabienne Marcellin, Nicolas Lorente, Baptiste Demoulin, et al.
Sexually Transmitted Infections|October 20, 2009
Prevalence of unsafe sex with one's steady partner either HIV-negative or of unknown HIV status and associated determinants in Cameroon (EVAL ANRS12-116 survey)Aïssata Dia, Fabienne Marcellin, Renée-Cécile Bonono, et al.
AIDS Care|February 9, 2010
Desire for a child among HIV-infected women receiving antiretroviral therapy in Cameroon: results from the national survey EVAL (ANRS 12-116)Fabienne Marcellin, Camelia Protopopescu, Claude Abé, et al.
AIDS Care|January 20, 2018
Acceptability of HIV cure-related trials: the challenges for physicians and people living with HIV (ANRS-APSEC)Marie Preau, Marjolaine Doumergue, Christel Protiere, et al.
Plos One|February 6, 2013
Impact of HIV comprehensive care and treatment on serostatus disclosure among Cameroonian patients in rural district hospitalsMarie Suzan-Monti, Charles Kouanfack, Sylvie Boyer, et al.
AIDS (London, England)|April 15, 2020
Who are the persons living with HIV who might refuse to participate in HIV cure-related clinical trials with treatment interruption?Christel Protiere, Marion Fiorentino, Abdourahmane Sow, et al.
Plos One|May 8, 2025
Correction: Impact of HIV comprehensive care and treatment on serostatus disclosure among Cameroonian patients in rural district hospitalsMarie Suzan-Monti, Charles Kouanfack, Sylvie Boyer, et al.
Vaccines|June 27, 2020
Characterization of Physicians That Might Be Reluctant to Propose HIV Cure-Related Clinical Trials with Treatment Interruption to Their Patients? The ANRS-APSEC StudyChristel Protiere, Lisa Fressard, Marion Mora, et al.
Pageof 34

Showing results (191-200 of 335) with videos related to

Sort By:
Pageof 34
Drug and Alcohol Review|April 14, 2016
No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort)Fabienne Marcellin, Caroline Lions, Eric Rosenthal, et al.
BMJ Open|April 3, 2012
ANRS-COM'TEST: description of a community-based HIV testing intervention in non-medical settings for men who have sex with menKaren Champenois, Jean-Marie Le Gall, Cédric Jacquemin, et al.
Sexually Transmitted Infections|August 7, 2014
Comparison of risk factors in HIV-infected men who have sex with men, coinfected or not with hepatitis C virus (ANRS VESPA2 French cross-sectional national survey)Fabienne Marcellin, Nicolas Lorente, Baptiste Demoulin, et al.
Sexually Transmitted Infections|October 20, 2009
Prevalence of unsafe sex with one's steady partner either HIV-negative or of unknown HIV status and associated determinants in Cameroon (EVAL ANRS12-116 survey)Aïssata Dia, Fabienne Marcellin, Renée-Cécile Bonono, et al.
AIDS Care|February 9, 2010
Desire for a child among HIV-infected women receiving antiretroviral therapy in Cameroon: results from the national survey EVAL (ANRS 12-116)Fabienne Marcellin, Camelia Protopopescu, Claude Abé, et al.
AIDS Care|January 20, 2018
Acceptability of HIV cure-related trials: the challenges for physicians and people living with HIV (ANRS-APSEC)Marie Preau, Marjolaine Doumergue, Christel Protiere, et al.
Plos One|February 6, 2013
Impact of HIV comprehensive care and treatment on serostatus disclosure among Cameroonian patients in rural district hospitalsMarie Suzan-Monti, Charles Kouanfack, Sylvie Boyer, et al.
AIDS (London, England)|April 15, 2020
Who are the persons living with HIV who might refuse to participate in HIV cure-related clinical trials with treatment interruption?Christel Protiere, Marion Fiorentino, Abdourahmane Sow, et al.
Plos One|May 8, 2025
Correction: Impact of HIV comprehensive care and treatment on serostatus disclosure among Cameroonian patients in rural district hospitalsMarie Suzan-Monti, Charles Kouanfack, Sylvie Boyer, et al.
Vaccines|June 27, 2020
Characterization of Physicians That Might Be Reluctant to Propose HIV Cure-Related Clinical Trials with Treatment Interruption to Their Patients? The ANRS-APSEC StudyChristel Protiere, Lisa Fressard, Marion Mora, et al.
Pageof 34